Dr Sabine Dittrich
Honorary Visiting Research Fellow
Dr Sabine Dittrich is a public health microbiologist passionate about diagnostic and how we can best utilize different tools and interventions to support patient management and public health interventions. Her work has predominantly focused on the epidemiology of zoonoitic and vector-borne diseases and how the lack of diagnostic tools impacts patient management and care decisions, including the overuse of antibiotics. She has been supporting the development of appropriate diagnostic tools from the local level at the Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit to the global level in Geneva at FIND, the global alliance for diagnostic. Sabine’s research utilizes laboratory and clinical studies to understand the use of diagnostic tools and pragmatic use data to inform product development, diagnostic algorithms, and strategies.
Sabine holds an engineering degree in Biotechnolgy (Dipl. Ing), a PhD in Biomolecular Science from the University of Manchester (UK) and subsequently completed a fellowship with the European CDC on public health microbiology (EPIET/EUPHEM) and outbreak response, based at the Dutch National Institute of Public Health.
Evaluations of training and education interventions for improved infectious disease management in low-income and middle-income countries: a systematic literature review.
van Dorst PWM. et al, (2022), BMJ open, 12
Performance and utility of more highly sensitive malaria rapid diagnostic tests.
Slater HC. et al, (2022), BMC infectious diseases, 22
Antigen-based Rapid Diagnostic Testing or Alternatives for Diagnosis of Symptomatic COVID-19: A Simulation-based Net Benefit Analysis.
Kendall EA. et al, (2021), Epidemiology (Cambridge, Mass.), 32, 811 - 819
Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID-19 in people with SARS-CoV-2
Verbakel JY. et al, (2021), Cochrane Database of Systematic Reviews, 2021
Anticipating the future: prognostic tools as a complementary strategy to improve care for patients with febrile illnesses in resource-limited settings.
Chandna A. et al, (2021), BMJ global health, 6